Free shipping on all orders over $ 500

Antibody-Drug Conjugates (ADCs) Antibody-Drug Conjugates

Cat.No.  Name Information
M24699 Vandortuzumab vedotin Vandortuzumab vedotin (DSTP 3086S) is an antibody-drug-conjugate to target prostate cancer.



 
Get to Know Us
Customer Support
Resources
Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.